Objective Development of quantitative, safe and rapid techniques for assessing embryo quality provides significant advances in Assisted Reproductive Technologies (ART).
not modified during spontaneous activation. Exposure to chemotherapy induced a dose dependent increase of Akt-P and rps6-P levels and of apoptosis. Hippo pathway was also affected by chemotherapy with an increase of CNN2 expression after 48h. After cutting, Hippo disruption was confirmed by the increase of CCN2 expression at 4h. Sectioning and chemotherapy exposure induced an increase in the growing follicles proportion compared to fresh ovaries but this difference was not significant compared to spontaneous activation. EVE significantly decreased rps6-P levels and prevented spontaneous and chemotherapy-induced follicular activation. Moreover, EVE was able to prevent the chemotherapy induced CCN2 expression.
Conclusions
In vitro follicular activation was moderated in the mice model and involved both PI3K/Akt/mTOR and Hippo pathways. EVE partially inhibits the follicular activation through a decrease of both PI3K/Akt and Hippo effectors suggesting a cross-talk between these two pathways. Inhibition of the PI3K pathway seems to be a promising approach to regulate follicular activation in vitro and reduced chemotherapy-induced "burn out effect". Objective Studies on risk assessment of environmental toxicants, drug development and animal's fecundity are solely structured on quantifying methodologies in gametogenesis. Besides advancement in 3D computational concept, computerized tools and software, conventional stereological approaches are still robust and reliable to ascertain risk assessment of malathion intoxication on spermatogenesis in rodents.
Design
Current study determined the more susceptible period of malathion intoxication to testicular machinery of mice during postnatal periods.
Material and Methods
For this purpose male mice (n=12) were exposed to two doses of malathion, low (50mg/Kg/day) and high (100mg/Kg/day), during three development periods, infant, juvenile and adult periods, from onset to consecutive 20 days. The testicular structural and functional integrity was determined by stereological analysis including volumetric density approach (VDA) and optical dissector approach (ODA) and statically compared employing two-way repeated measure ANOVA.
Results
The morphometric analysis ascertained the significant (P<0.05) decrease in mean testicular volume, weight, length and width of mice treated at juvenile period with both malathion treatments compared to sham and mice treated at adult period. However, the mean seminiferous tubule diameter was appreciably increased in mice treated at juvenile period with malathion doses. The ratio of volume density of seminiferous epithelial thickness to round spermatids (Vvepi-t:Vvrnd-sp) was noticeably (P<0.001) the highest in testis exposed to malathion doses during juvenile period compared to other treatments. Moreover a tremendous 47% and 6% decline was estimated through VDA, in round spermatid population of testes treated with both malathion doses during juvenile and adult periods respectively.
Conclusions
The juvenile period for malathion intoxication was found more potent than others while volume density ratios were ensued worthwhile to evaluate the reproductive toxicity. Labaid specialized Hospital, Dhanmondi, Bangladesh Background Anti-Mullerian hormone (AMH), a member of the transforming growth factor-β (TGF-β) superfamily, is known to be derived from the granulosa cells of growing follicles. AMH is emerging as an important regulator of ovarian function, especially follicle selection and development. AMH affects oocyte development during folliculogenesis, and the levels of AMH in the follicular fluid may affect embryo quality and the ability of the oocyte to function. So the prediction of in vitro fertilization outcomes by AMH measurement is getting importance now a days.
Support None

20: PREDICTIVE VALUE OF SERUM AND FOLLICULAR FLUID AMH LEVEL AS
Objective
Whether serum and follicular fluid (FF) AMH level is related to success of fertilization and better embryo quality?
Design
Prospective study included women with presence of both ovaries and the absence of other endocrine pathologies . Couple with Male factor infertility were excluded from the study.
Material and Methods
This prospective study was conducted at two IVF center (Lab-aid IVF center and Hope infertility Center) from November 2016 to October 2017. A total of 70 infertile patients underwent IVF treatment during this period are taken as participant. Serum AMH were measured on day 3 of the cycle and follicular fluid AMH were measured on the day of oocyte retrieval by ELISA (Enzyme-linked Immunosorbent assay). The relationship of serum and follicular fluid AMH level and IVF outcomes in terms of number of oocyte retrieved, number of mature oocyte, fertilization, good quality embryo and clinical pregnancy were assessed.
Results
Serum AMH level showed a positive correlation with number of oocyte retrieved, number of mature oocyte, number of fertilization, good quality embryo and clinical pregnancy (p ≤0.01). On the other hand FF AMH levels do not show statistically significant correlation with any of the IVF outcomes mentioned above.
Objective Sperm DNA fragmentation (SDF) is an important function test showing inverse relation with spontaneous and assisted reproduction. Medical treatments to improve SDF with antioxidants have given controversial results. The objective of this study was to examine the effect of an antioxidant regimen on seminal oxidative stress (OS) and SDF.
Design
Prospective clinical trial
Material and Methods 101 infertile men with abnormal semen analysis were included in the study. A combined antioxidant supplement containing L-carnitine, CoQ10, Vitamin E, Lycopene, N-Acetyl-l-cysteine, and other nutrients (FH PRO, Fairhaven Health, Bellingham, WA) was prescribed 3 tablets twice daily for 3 months. Semen samples were analyzed before and after treatment according to WHO 5thedition. ORP (a marker of OS) was measured using MiOXSYS analyzer while SDF was measured using the Halosperm kit (cut-off: ≤30%).
Results
All patients (primary infertility: n=71; secondary infertility: n=30; mean duration: 5.9±4.2years; mean age:35.7±6.6years) completed the trial. Compared with the pre-treatment results, there was significant increase in sperm count(from 23.1±2.6 to 30.8±2.8, p<0.001), progressive motility(from 4.1±0,7 to 9.1±1.1, p<0.001) and normal morphology(from 2.85±0.3 to 4.62±0.3, p<0.001). ORP decreased significantly from 12.2±2.2 to 6.8±1.6mv/106/mL(p 0.014). SDF test was done in 72 patients of which 41 had elevated SDF before treatment while 31 were normal. In all patients, SDF significantly decreased from 36.3±2.3% to 29.04±1.9%. Specifically, SDF decreased significantly in 35 out of 41 patients with high initial value (from 51.7±2.2 to 33±2.1, p<0.001). Further, SDF became normal in 17/41 patients(41.5%) with high SDF, while 43.9%(n=18/41) showed significant reduction, but were still high.
Conclusions
Three months antioxidant treatment (FH PRO) resulted in significant reduction in SDF and seminal OS, and significant improvement in sperm count, progressive motility and morphology. 
Support None 1 9 : VA R I A N T O F F S H Β G E N E A F F E C T H U M A N REPRODUCTION OUTCOMES
Faculdade de Medicina do ABC, Brazil
Objective FSH is essential on the hypothalamic-pituitary-gonadal axis exerting a key play in human reproduction. The β-subunit, encoded by FSHβ gene, is responsible to ensure the binding specificity to FSHR. A promoter polymorphism in this gene, c.-211G/T (rs10835638), is associated to decreased gene transcription in gonadotroph cells. We aimed to investigate the possible effects of FSHβ c.-211G/T polymorphism on hormonal profile and in vitro Fertilization (IVF) outcomes in normoovulatory infertile Brazilian women.
Design
Cross-sectional study.
Material and Methods 140 infertile women (32.4±3.5 years old) mainly caused by male or tuboperitoneal factors underwent IVF treatment were studied. FSH, estradiol, LH, progesterone, prolactin and AMH levels, as well as antral follicle counting were evaluated on the 2nd-3rd day of menstrual cycle. Genotyping was performed using TaqMan methodology by real time PCR.
Results
The polymorphic allele T was found in 13.6% of women, only observed in heterozygose. The age, BMI, menarche, menstrual cycle interval, infertility duration and daily dose of rFSH to controlled ovarian hyperstimulation to IVF treatment were not different between women carrying GG or GT genotype. However, carriers of GT presented almost double of poor response to controlled ovarian hyperstimulation (47.4% versus 26.5%, p=0.010), higher LH levels (3.1 IU/mL vs. 2.4 IU/mL, p=0.0002) and lower antral follicle counting (8.0 vs. 10.0, p=0.03), oocytes retrieved (3.0 vs. 5.0, p=0.03), MII (3.0 vs. 4.0, p=0.02) and embryos (2.0 vs. 3.0, p=0.02). Despite this, no difference was observed in pregnancy rate.
Conclusions
The increased LH levels, despite being within the normal range, may have interfered in the follicular growth and oocyte maturation, and consequently IFVoutcomes observed in women with GT genotype. FSHβ c.-211G/T polymorphism may alter some aspects of the female reproductive system and reproductive outcomes. 
Support
Objective
The study of single nucleotide polymorphisms (SNPs) in candidate genes that regulate reproductive function may help to clarify the mechanisms responsible for gonadal function and fertility in humans. We aimed to evaluate SNPs in FSHR, AMH, AMHR2, ESR1, ESR2, CYP17A1, CYP19A1, COMT, MTHFR, BMP15, GDF9, FOXL2, LHX8 and NANOS3 genes as predictors of response to controlled ovarian hyperstimulation (COH) and in vitro fertilization (IVF) outcomes.
Design
Material and Methods 188 normovulatory women (32.5±3.4 years old) with infertility mainly caused by male, tuboperitoneal or idiopathic factors underwent IVF treatment were studied. FSH, estradiol and AMH levels, as well as antral follicle counting (AFC) were evaluated on 2nd or 3rd day of the menstrual cycle. Genotyping were performed by real-time PCR using TaqMan assay.
Results GG genotype of AMHR2 rs11170555/G>A was associated lower AMH levels, while CC genotype of MTHFR rs1801131/A>C to higher AMH levels and AFC, and TT genotype of MTHFR rs1801133/C>T to lower AFC. Considering the response to COH, TT genotype of AMH rs10407022/G>T and GA of ESR2/rs4486938/G>A were more frequently found in satisfactory ovarian response, while GA genotype of AMHR2 rs3741664/G>A and CC genotype of MTHFR rs1801131/T>C in excessive response. The combination AMHR2/rs3741664 and MTHFR/ rs1801131 or AMHR2/rs3741664 and ESR2/rs4486938 increases the chance of excessive response. AA genotype of FSHR/rs6165 was associated to higher numbers of oocytes retrieved and MII, meanwhile AA genotype of AMHR2/rs11170555; CC of AMHR2/rs2071558; GG of AMHR2/rs3741664 and TT genotype of AMHR2/rs2002555 were associated to lower numbers of oocytes retrieved and MII.
Conclusions
Genetic variation in AMH rs10407022 and ESR2 rs4986938 polymorphisms are associated to good response, meanwhile, AMHR2 rs3741664 and MTHFR rs1801131 polymorphisms are associated to excessive response to controlled ovarian hyperstimulation. Besides, these SNPs also influenced number of retrieved oocytes and MII in Brazilian infertile women.
Support FAPESP #2014/06177-2. 
31: ELEVATED ESTRADIOL LEVELS DURING HORMONE R E P L A C E M E N T T H E R A P Y I N F R O Z E N E M B RY O T R A N S F E R C Y C L E S N E G A T I V E LY A F F E C T S IMPLANTATION RATE OF EUPLOID EMBRYOS
Objective
Supraphysiologic levels of estradiol during fresh in vitro fertilization cycles have been associated with poor pregnancy outcomes. The objective of this study was to determine if peak serum estradiol concentrations during hormone replacement therapy (HRT) in preparation for frozen embryo transfer (FET) affects implantation rate of euploid embryos.
Design
Retrospective analysis of 99 HRT-FET cycles with euploid embryo(s).
Material and Methods
Charts were reviewed for patients who underwent a HRT-FET cycle with a euploid embryo(s) between January 2017 and April 2018. Patients received oral and vaginal estradiol or oral, vaginal and transdermal estradiol until a minimum 7.5 mm trilaminar lining was achieved. Progesterone supplementation was administered intramuscularly and vaginally for 5 days prior to embryo transfer. Serum estradiol levels were measured before progesterone was inititaed. Implantation rate was determined by the number of heartbeats visualized divided by the number of embryos transferred. The statistical significance was set at p<0.05, and data was analyzed using a two sample t-test.
Results
Implantation rate for patients with a peak E2 < 1000 pg/ml (63.2%) was higher (p=0.014) than for patients with a peak E2 > 1000 pg/ml (45.9%). There was no statistical difference in the number of embryos transferred or age of patients between groups. We can say with 95% confidence that patients with a peak E2 < 1000 pg/ml will have 2.48 to 4.19 higher implantation rate than patients with E2 > 1000 pg/ml.
Conclusions
Our analysis demonstrated that elevated serum estradiol levels during a HRT-FET cycle results in a lower implantation rate. The use of preimplantation genetic testing served to minimize implantation failure as a result of aneuploidy. Based on this data, we think estradiol administration should be adjusted to maintain a lower estradiol level during HRT-FET cycles. Larger, prospective studies need to be conducted to determine the optimal range of estradiol in a HRT-FET cycle to optimize implantation rates. Objectives Epithelial ovarian cancer (EOC) is one common pathological type in ovarian cancer, and EOC is known as a familiar gynecological cancer today. In recent years, it has been found that microRNAs and long chain non-coding RNA (lncRNA) regulate the transcriptional expression of chromosomal DNA in cells. However, it is not well understood that the upstream and downstream regulatory molecules of lncRNA HOTAIR, which regulate the growth and migration of tumor cells.And the related mechanisms need to be studied.
Support
Materials and Methods
The reconstructed miR-200c lentivirus was obtained and transducted into ovarian cancer SKOV3 cells. The characteristics of miR-200c overexpression SKOV3 cells were analyzed from the assays of invasion and nude mouse tumorigenicity, as well as the expression of lncRNA HOTAIR, snail and E-cadherin mRNA detected by real time PCR, and snail detected by immunohistochemistry and west blot methods in xenograft tumors, respectively.
Results
The miR-200c and lncRNA HOTAIR expression was proved by RT-PCR in SKOV3 cells. The lentivirus-miR-200c SKOV3 cells show that the invasion ability was significantly decreased compared with the negative control (P<0.01). The nude mouse tumorigenicity, including tumorigenicity mouse number and tumor volume, was significantly decreased compared with the control group (P<0.01). The snail protein expression detected by IHC and west blot in lentivirusmiR-200c-SKOV3 xenograft tumor was significantly decreased compared with the negative control lentivirus-SKOV3 group (P<0.05). The miR-200c overexpression resulted in lncRNA HOTAIR low expression, increasing E-cadherin and decreasing snail expression detected by quantitative RT-PCR in the lentivirusmiR-200c transducted SKOV3 cells of xenograft tumor, compared with the negative control (P<0.05).
Conclusion
The miR-200c overexpression in SKOV3 cells with transducted lentivirus-miR-200c can inhibit lncRNA HOTAIR expression, decrease snail, increase E-cadherin and significantly reduce the invasion and tumorigenicity of epithelial ovarian cancer SKOV3 cells. These results suggest that the miR-200c and lncRNA HOTAIR could be effective therapeutic targets for human epithelial ovarian cancer treatment. Material and Methods PCOS patients were identified using the Rotterdam criteria from a university-based hospital. Patients were evaluated for anthropometric data, androgenic data, metabolic profiles, markers of inflammation and oxidative stress following 3, 6 and 12 months of metformin use. Changes in values were evaluated using the lineal mixed models.
Results
Neither 8-OHdG and MtDNA were correlated to baseline body weight, age or insulin levels. Levels of 8-OHdG and MtDNA were also not correlated at baseline. Progressive decrease in both 8-OHdG and MtDNA were seen in patients with PCOS following metformin use. The levels of 8-OHdG were 34.62 (27.7-45.4), 31.94 (23.18-42.10), 29.96 (21.21-39.09), and 8.57 (12.14-31.15 ) at baseline, 3, 6, 12-months, respectively (p < 0.0001), while levels of MtDNA were 55.38 (26.14-100.3), 34.78 (19.67-74.68), 33.42 (20.48-55.67), and 24.11 (17.16-66.13 ), respectively (p < 0.0027).
Conclusions
In this study, we demonstrate the both 8-OHdG and MtDNA decreased in patients with PCOS who received metformin for 12 months. This demonstrates that metformin is associated with improved oxidative profile in patients with PCOS.
Support
This study was supported by grant from the Ministry of Science Technology of Taiwan (MOST 105-2628-B002-043-MY4). 
33: ELUCIDATING APOPOTIC GENE EXPRESSION SIGNATURES IN BLASTOCOEL FLUID FROM EUPLOID B L A S T O C Y S T S T H AT A R E A S S O C I AT E D W I T H PREGNANCY OUTCOMES
Objective
Uncovering the molecular mechanisms that regulate early development is crucial to understanding why the transfer of euploid embryos does not always result in a live birth. Apoptosis occurs during pre-implantation embryo development and possibly serves as a corrective mechanism to sacrifice cells for overall embryo competence. Remnants of early apoptosis can be detected in blastocoel fluid. Not all euploid embryos successfully implant which may be due in part to altered apoptosis during preimplantation development. This study compared apoptotic gene expression in an embryo that resulted in a live birth, with other euploid (3 leading to pregnancy and 3 resulting in loss of pregnancy) and aneuploid embryos using blastocoel fluid from each day-5 embryo.
Design
Retrospective analysis of day-5 euploid blastocoel apoptotic gene expression and implantation outcome.
Material and Methods
Following laser-assisted trophectoderm biopsy of ICSI-generated day-5 blastocysts, each individual blastocoel fluid-conditioned medium (25μL) was saved. Biopsied cells were assessed for ploidy status via nextgeneration sequencing. Gene expression in blastocoel fluid was assessed by RT-PCR utilizing TaqMan arrays for human apoptosis genes (92 genes total).
Results
Increased gene expression of caspase-7, an executioner caspase, was observed in pregnancy positive blastocoel fluid samples, but was not detected in pregnancy negative samples (or in aneuploidy samples). Increased gene expression of Bcl-2-like protein 13 (Bcl2-L-13) was detected in embryos that did not implant.
Conclusions
This study provides preliminary evidence that apoptotic gene expression in blastocoel fluid from day-5 euploid embryos differs between embryos that successfully implant versus those that do not. Successfully implanted embryos (one yielding live birth) exhibited increased expression of an apoptosis activator, caspase-7. Bcl2-L-13 gene expression was detected to a higher degree in embryos that failed to implant. This mitochondrial gene plays a role in mitophagy as well as inhibiting apoptosis in some cancer cells. 
Support
Objective
We designed and implemented a HIPAA compliant mobile (smart phone) application to assess the clinical decision making of ART laboratory staff for more than 80 common andrology and embryology procedures, track new staff competency during employee on-boarding and annually thereafter, and provide statistics for staff-related IVF cycle parameters.
Design
The MySQL database, REST API, and administrator panel were developed with the HIPAA compliant laravel framework. Passport authentication, bio-metric log in and login with authentication, and encryption protect every aspect of the application. The andrology and embryology competency modules (ACM and ECM) provided standardized instruction to test-takers and were used to measure inter and intra-technologist variability between senior embryologists.
Materials and Methods
Over 80 competency assessment modules were created for sperm and embryo morphology, quality, viability and common clinical decision timepoints. Briefly, ACM used 32 images of PAP-stained morphology slides, and ECM used 112 cleavage stage images captured on EmbryoScope 66 hours post insemination, and 168 blastocyst stage images captured on EmbryoScope 115 and 139 hours post insemination. Each slide was rotated and repeated 3 times throughout the modules to allow for intra-observer variability measurements.
Results
The mobile (smart phone) application was programmed and validated on both iOS (Apple) and Google/ Android mobile devices at three different high volume IVF clinics. Highly trained senior embryologists completed the assesments to design a scoring rubric for ACM and ECM. Inter and intra-technician variability among senior staff was assessed to refine the competency assesment design for the next phase of the project; a multicenter validation trial.
Conclusion
Our mobile application is a novel new tool to monitor staff related quality assurance parameters in an IVF laboratory. Objective Improvements in oocyte cryopreservation(OC) have led to successful oocyte banking and more readily available cryopreserved donor oocytes(DO). Simultaneously, preimplantation genetic screening(PGS) has increased, even with DO. Using OC, DO, and PGS together is less common, but now occurs. Reservations include increased technological and financial cost ($1,100/oocyte). Our goal was to determine whether adding PGS increases implantation and live birth rates in DOT.
Design
Retrospective cohort study.
Material and Methods
We conducted a retrospective analysis of DOT performed 10/2004-1/ 2017 at a university-based fertility center. To remove bias, we conducted a sub-analysis of single embryo transfers(SET). Data was mined for: number of oocytes thawed/survived/fertilized, embryo development/ transfer/implantation, and ongoing pregnancy/live birth. Mood's median and Fischer's exact tests were used for statistical analysis.
Results
Within the 130 non-PGS DOT (118 pts, median age:26y), 1138 oocytes (median:8/cycle) were thawed. Within the 15 PGS DOT (15 pts, median age:24y), 180 oocytes (median:11/cycle) were thawed; a mean of 3 blastocysts(BL) were biopsied. Oocyte survival, 2-PN fertilization, BL formation, implantation, and ongoing pregnancy/live birth rates were not significantly different between the groups. The multiple birth rate in the non-PGS group was 6% (5/84 births). When controlling for SET, no differences were found in implantation or ongoing pregnancy/live birth rates with and without PGS (p>.1). When comparing embryo quality in the non-PGS group, a higher ongoing pregnancy/live birth rate was noted among SETs with excellent-quality Gardner's >2Bb (62%; 50 births/81 transfers) when compared with SETs with poor-quality Gardner's <2Bb (35%; 8 births/23 transfers; p=.03).
Conclusions
Due to this study's small sample size, it is difficult to conclude whether PGS improves implantation/live birth rates in a young donor population. In DO cycles with excellent-quality BL for transfer, morphology alone predicts a high live birth rate. Given the financial and technological burden of PGS, larger studies are needed to determine whether the costs of PGS outweigh the benefits in DO cycles. (Istanbul, Turkey; Project No: 26.06.2015 -1331 . Study group was designed according to the families all of which applied to assisted reproductive technologies as a result of male infertility.
Support None
59: MOLECULAR BASIS OF PATERNAL MITOCHONDRIAL D N A T R A N S M I S S I O N
A N D M O N I T O R I N G O F DEVELOPMENTAL MITOCHONDRIA ELIMINATION IN HUMAN E K E R , C A N D A N 1 ; G O K S E V E R C E L I K , H A L E 2
Material and Methods
A total of 16 trios (48 individuals) which contain 7 newborns and 9 infants born by in vitro fertilization method (IVF-ICSI) and their parents were studied using "Illumina, MiSeq" next-generation sequencing platform. Total genomic DNA was isolated from either peripheral blood lymphocytes or cord blood samples. Mitochondrial DNA genome was amplified using two special primer pairs by polymerase chain reaction method to generate the entire human mitochondrial genome. Sequencing reads were analyzed in mitochondrial DNA databases and the results were evaluated within each family.
Results
Sequencing analysis results were investigated on the basis of "motherfather-child", "mother-child" and "father-child". In 14 "trios" of 16; maternal mitochondrial DNA haplotype were detected for children, the remaining 2 "trios" had different mitochondrial DNA haplotypes when compared to their mother and fathers. Also; "father-child" sharing same genetic variants (SNP ("Single nucleotide polymorphism") / "Multiple nucleotide polymorphism" / INDEL ("Insertion/Deletion") were found in 8 "trios". In 5 "trios" of 16; 98-99% paternal mitochondrial DNA genome sequence similarity were obtained by alignment of "father-child" mitochondrial DNA genome.
Conclusions
This study is the first whole mitochondrial genome investigation for paternal mitochondrial DNA effect on assisted reproductive technology applications working on the molecular basis of paternal mitochondrial DNA transmission in human. Background Adverse obstetrical outcomes associated with IVF/ICSI are well established. As use of FET has become more widespread, evidence has emerged that FET is associated with adverse outcomes of its own, including a higher incidence of large-for-gestational age (LGA) infants and preeclampsia. Available studies have focused on embryo and patient factors, however none have accounted for the endometrial preparation protocol and resulting fluctuations in the hormonal environment at the time of implantation and in the first trimester.
Support
Objective To examine the impact of different endometrial preparation protocols for FET on obstetrical outcomes.
Design
Material and Methods
Eligible patients who underwent IVF/ICSI and FET treatment between January 1, 2014 and December 31, 2016 at an academic fertility clinic were included in our study. Research ethics board approval was obtained. All FET cycles used one of four methods of endometrial preparation -natural cycle(NC), hormone replacement using oral estradiol(HRT-O), HRT using vaginal estradiol (HRT-V), mild controlled ovarian stimulation(COS). Mean birthweight and gestational age at delivery were compared using Kruskal-Wallis test. Incidence of hypertensive disorders of pregnancy was compared using Fisher's exact test.
Results 2223 cycles resulting in 576 live births were included. Mean birthweight (grams ± standard deviation [SD] ) was significantly different between groups -fresh IVF/ICSI 3216 ± 602 (n=271), NC 3269 ± 693 (n=134), HRT-O 3562 ± 788 (n=29), HRT-V 3328 ± 707 (n=137), and COS 2988 ± 173 (n=5), P=0.006. Groups did not differ in terms of mean gestational age at delivery or incidence of hypertensive disorders of pregnancy.
Conclusions
Method of endometrial preparation for embryo transfer is associated with differences in mean birthweight. Further analysis is required to determine whether these differences can be attributed to the hormonal milieu produced by different methods of endometrial preparation or other aspects of the embryo transfer cycle. 
Support None
30: THE RELATIONSHIP BETWEEN BLASTOCYST DEVELOPMENT AND ESTRADIOL CONCENTRATION ON D AY O F H C G T R I G G E R A F T E R S TA N D A R D I Z E D CONTROLLED OVARIAN STIMULATION (COS)
HAMBROSE
Objective
To study the relationship between estradiol (E2) concentrations on day of human chorionic gonadotropin (hCG) trigger and embryo development after a standardized COS protocol for in vitro fertilization (IVF).
Design
Prospective study of 218 IVF cycles from 2016 and 2018 in a private IVF center.
Material and Methods
Women 21-41 years of age were screened using strict inclusion criteria including anti-Mullerian hormone >1.0 ng/ml, follicle stimulating hormone (FSH) ≤10 IU/mL, luteinizing hormone <12 IU/ mL, E2 <50 pg/mL on day 2-4 of menstrual cycle. Patients received a start dose of 300 IU/day of recombinant FSH or highly-purified human menopausal gonadotropin for the first five days of stimulation. Thereafter, patients underwent individual adjustments up to a total of 450 IU/day to optimize ovarian response. hCG was used to trigger maturation when 3 follicles reached 17mm, and oocyte retrieval was performed 36 hours later. Embryos were graded using the Society for Assisted Reproductive Technology standardized system. The percentage of usable blastocysts after 5-6 days of culture was defined as the percentage of 2 pronuclear (2pn) zygotes that had developed into good-quality blastocysts that where transferred or frozen. Statistical analysis was performed a using two-sample t-test and Minitab 18. Statistical significance was set at P<0.05. Means ± standard error of the mean were calculated.
Results
The mean percentage of 2pn zygotes that developed into usable blastocysts when E2 on day of hCG trigger was <2500 pg/ml was 44.5 ± 2.2 (n=142), which was higher (P=0.003) than when it was >2500 pg/ml (n=76) at 35.9 ± 2.2.
Conclusions
There is debate in the literature about whether supraphysiological concentrations of E2 on day of trigger have a direct effect on embryo development. In this study, we found that an E2 greater than 2500 pg/ml on the day of hCG trigger was associated with lower percentage of usable blastocysts that developed from 2pn zygotes. 
Support None
68: MOLECULAR PROFILING OF ENDOMETRIAL GLAND FORMATION USING SINGLE-CELL ANALYSIS
Objective
The endometrium is comprised of luminal and glandular epithelia that develop from a single progenitor layer of fetal uterine epithelium that expresses Wnt7a. Gland morphogenesis occurs postnatally and depends on a number of genes including FoxA2. This study aims to systematically characterize the molecular mechanisms of luminal and glandular epithelial specification by single-cell sequencing.
Design
In vivo, descriptive study using a transgenic mouse model for isolation of primary endometrial cell populations during postnatal development.
Material and Methods
A transgenic mouse line expressing tdTomato fluorescent protein following Wnt7a-Cre-mediated recombination was used to trace the bifurcation of luminal and glandular fates from ancestral fetal epithelium. Uteri were dissected at several postnatal time points and analyzed for Wnt7a-reporter (tdTomato) expression and gland formation by immunofluorescence. ECadherin antibody was used to mark luminal/glandular epithelia; FoxA2 anitbody was used to identify glands.
Results
Wnt7a-reporter was undetectable in the P0 uterus. P7 uteri showed strong Wnt7a-reporter expression in the luminal epithelium, overlapping with ECadherin. Small epithelial invaginations were observed at this stage, but none were FoxA2 positive. P11 uteri showed considerable gland morphogenesis with Wnt7a-reporter expression in luminal and glandular epithelia. FoxA2+ cells were observed budding off from the luminal epithelium and in fully formed glands within the stroma. Gland formation was completed by P17, with all FoxA2+ cells contained within glands completely surrounded by stroma.
Conclusions
Combining a tissue-specific reporter mouse line with immunofluorescence allowed us to identify and track three distinct cell populations during postnatal endometrial development: luminal epithelia (tdTomato+, E-Cadherin+ , FoxA2-), glandular epithelia (tdTomato+, E-Cadherin+, FoxA2+), and stroma (triple negative). We plan to use this as the basis for cell sorting and subsequent single-cell sequencing to establish distinct molecular signatures for luminal and glandular epithelia. These transcriptomic profiles will allow us to explore the independent and synergistic functions of these two cell types during implantation and decidualization. 
Objective
The purpose of the study was to better understand donor-conceived adults and their individual differences with regards to viewing their own donor conception, their desire to search for the donor, search methodologies used, and if the donor was found, how they defined that relationship.
Design
Online questionnaire for adult donor offspring with qualitative and quantitative questions.
Material and Methods
The online survey was made available to Donor Sibling Registry members 12/17-1/18. Results 3.9% (19) of respondents were conceived with an egg donor, 466 (96%) with a sperm donor. 76.5% female, 20.3% male. The age range was from 18-74. Disclosure: 85.1% were told that they were donorconceived by their parents, 3.3% by "someone else", 11% found out "on their own". Searching: 70.3% tried to find their donor, 29.6% had not done so. Methods used for finding donors: (participants could select all that applied): 17.6% used record searches, 24.1% utilized DNA testing, 21.2% contacted the clinic/doctor/sperm bank, 31.6% used the DSR. Contacting donors: 30.9% found their donor, 66.6% attempted contact. 16.7% through social media, 11.8% via DNA testing, 11.3% through the DSR, 26.7% sent a letter, 11.8% called/texted, 15.8% reached out to the donor's family, and 5.9% used other means of contact. 84% agreed with the statement, "I think a lot about the characteristics I might share with my donor." 60.7% agreed, "I understand myself better because I have thought about who I am in relation to my parents and donor."
Conclusions
Conclusions/feelings about being donor-conceived: 50.4% agreed, "I am still trying to figure out how donor conception relates to who I am", 15% felt angry about being donor-conceived, 73.1% said they did not. 10.4% felt embarrassed about being donor-conceived, 7.5% felt ashamed, and 15.3% like to keep it a secret. 69% are happy to tell anyone about their donor conception. ; JUN, JIN HYUN embryos did not significantly affect blastocyst development and outgrowth potential. Interestingly, ZP-free 4-cell embryos with 5-point contacts in blastomeres showed significantly shorter mean cumulative time of development from 2-cell to blastocyst stage compared with those which had 4-point contacts. In addition, early compacted embryos before the 8-cell stage but with intact ZPs showed low developmental competence to blastocyst stage. This study has shown that the removal of the ZP does not affect blastocyst development and outgrowth potential in vitro in mice 2-cell embryos.
Collectively, we suggest that modification of ZP could apply various purposes without decreasing developmental competence in mice 2-cell embryos.
Support
This project was financially supported by a Korea Healthcare Technology R&D Project grant from the Ministry of Health and Welfare (A120043). 
37: CORRELATION BETWEEN MORPHOLOGIC GRADING AND EUPLOIDY RATE OF BLASTOCYSTS, AND CLINICAL OUTCOMES IN IVF-PGS CYCLES
Design
Retrospective cohort study
Material and Methods
This is a retrospective study using the medical records of patients who underwent IVF procedures with PGS between January, 2016 and February, 2017 in a single center. Total of 136 IVF cycles were included. The embryo grades were categorized into 4 groups: Excellent, Good, Average, and Poor. Basic characteristics, euploidy rates, clinical pregnancy (CP) rates and ongoing pregnancy rates were analyzed.
Results
The Excellent group had significantly higher rate of euploid embryos than Average group (47.82% vs. 29.33%, P = 0.023) and group P (47.82% vs. 29.60%, P = 0.005). When the four groups were recategorized into two groups (Excellent & Good vs. Average & Poor), they also showed significant difference in euploidy rates (44.52% vs. 29.53%, P = 0.002). The total CP rate was 46.4%. When the patients were divided into two groups by age 35, the CP rates for those under and over 35 years old were 44.74% and 47.83%, respectively, which showed no significant difference.
Conclusions
The significant differences among the euploidy rates of different morphologic embryo grades demonstrated the positive correlations between the morphologic grading of the embryo and the euploidy rate of PGS. Additionally, there was no significant difference between the younger and older patients' CP rates, which emphasizes the fact that PGS might be indicated for older patients. Objective The mainstream technology of Artificial Intelligence(AI) transferred from expert system to machine-learning and recently created deep-learning, which has shown superiority in medicine because of its formidable ability to process big data. Reproductive medicine relies on endocrinological and imageological analysis and precise experimental technology, which provided a fertile territory for AI. This review aimed to demonstrate the status quo and future possibility of AI in reproductive medicine and the potential dilemma it could bring about Design A systematic review.
Material and Methods
The PubMed, MEDLINE database, Wiley online library, IEEE database and several professional books of computer science up to July 2018 were searched.
Results AI achieved high precision in screening, classification, prognosis prediction, cross-regional management of different kinds of diseases using finite information, which is comparable, sometimes even superior to human specialists. Integration with frontier technology such as radiomics, DNA-based neural networks extends its potential in medical practice. Although limited, several attempts had been made in reproductive medicine. Machine learning-based decision support systems developed to predict the success rate of IVF/ICSI cycle had acquired improving accuracy. AI had also been applied to mine secluded information of computer-aided sperm analysis. The combination of time-lapse technique and AI algorithm and semi-automatic blastocyst grading system heightened objectivity of embryo culture. Deep-learning may assume a central role in future development in clinical data collection, ovulation induction protocol adjustment and improvement of embryo culture and transfer techniques. Nevertheless, there remains some issues to be parsed, including subjective bias of raw data caused by human, incoordinate development between software and hardware, the transformation from patients' flexible and colloquial data to standardized clinical profile, and immature ethical and legal regulation.
Conclusions
The promising prospect of AI deserves future collaborative efforts of clinicians in reproductive medicine, computer scientists, and industrialists. 
Support None 4 2 : D O E S S T R E S S A F F E C T I V F O U T C O M E S ?
J Assist Reprod Genet
Objective Fertility treatments are known to be related to emotional stress. Yet, it remains unclear whether stress has an effect on in vitro fertilization (IVF) cycle outcomes. The aim of this study was to evaluate the effect physiological and emotional stress on fertility outcomes for women going through IVF treatments.
Design
A prospective cohort of 73 women undergoing IVF treatment was conducted.
Material and Methods
Physiological stress evaluation included saliva cortisol measurements and emotional stress included stress questionnaires (HADS Hospital Anxiety and Depression Scale, 1-10 Stress scale). These were measured at 3 time points:1. prior to IVF treatment starting, 2. At day of oocyte pick up (OPU) 3. At day of embryo transfer (ET). In addition, cortisol level in the follicle was also measured on the day of OPU. Association between stress levels (cortisol and questionnaires) and fertility outcomes, including: number of retrieved oocyte, number of embryos, embryo quality, fertilization rate and pregnancy rate were measured.
Results
Emotional stress levels and Salivary cortisol levels were the highest on day of OPU compared to levels prior to treatment and to the level at ET day. Emotional stress level measured by HADS prior to IVF treatment, was associated with lower maximal estrogen level (p=0.034) and lower number of fertilized oocytes (p=0.032), yet no relation to pregnancy rate (p=0.883) was found. Salivary cortisol was not related to fertilization rate, embryos quality and clinical pregnancy rate. However, follicle cortisol level was negatively correlated with number of eggs retrieved (p=0.018) and lower endometrium thickness (p=0.05).
Conclusion
Though emotional and physiological increase during IVF treatment are highest on day of OPU, this elevation was not associated with pregnancy rate. These findings might reassure women who are afraid that their stress level will affect their IVF outcomes. Objective Evaluation of the effects of an oral antioxidant supplementation, associated with a Mediterranean diet, on the spermatic parameters of "idiopathic" male infertility.
Design 240 men with idiopatic infertility , partner of a couple seeking fertility assistance were retrospectively followed from Janvier 2018 to juin 2018 (EHUO hospital). We included randomised controlled trials, comparing a combined thérapeutic taken by the male with no treatment.
Material and Methods 240 men seeking fertility assistance,and having 3 spermograms altered (we excluded azoospermia).Accompanied by our dieteticens, they followed a Mediterranean diet and took for three months an oral supplementation of a complex antioxidant.After 3 months, a spermogram was requested, and data analysing was done by the hospital's biostatician. The outcomes were evaluation of sperm parameters and adverse effects.
Results
After 3 months of treatment all the sperm parameters were significantly increased (p ≤ 0, 001) :Progressive Motility: (25% → 60 %) ; (65% of non motile spermatozoa became motile);Vitality: 40% → 70%; Normal count: 45% → 60 %; Normal morphology: 47.7% → 61% .We also improved the Pregnancy Rates (≥ 18.50%) after 9 months.No side effects have been reported.
Conclusions
Oral antioxidant therapy, combined with nutritional measures as Mediterranean diet, lead to a significant improvement in sperm parameters and fecundability, in "idiopathic" male infertility .However,it would be interesting to have a larger patient population over a longer period. Center for Advanced Reproductive Services, UConn, Farmington, CT, USA Objective Adult obesity rates now exceed 35% in five states. Connecticut's rate is currently 26.0%, up from 10.4 % reported in 1990 (1). Based on this alarming increase in obesity rates, we were interested in learning how deep the knowledge base is on this topic among patients seeking infertility treatment at the Center for Advanced Reproductive Services (CARS). Our objectives were to analyze our patients' perception of their BMI (Body Mass Index), comparing this to actual collected BMI, and to determine if weight and nutritional counseling should be part of our infertility care.
Support None
16: SHOULD A PATIENT'S KNOWLEDGE AND AWARENESS OF BMI ON THE EFFECTS OF INFERTILITY BE
A STANDARD OF CARE? N E U B E R , E V E LY N 1 ; D AVI E S , D A R L E N E 1 ; R E V O I R ,
Design
Prospective anonymous patient survey study.
Material and Methods
We created a 15 question anonymous, multiple-choice survey. Data was tallied using Survey monkey software. This study was exempt from the UConn Health Institutional Review Board.
Results 150 patients participated, 118 (79%) female, and 32 (21%) male. A majority (54%) of respondents did not know their current BMI, however 61% reported a current normal BMI (range18.5-24.9). According to actual data collected in 2017, only 41.9% of our patients fell in the normal range. 54% of the respondents indicated that their doctor had never mentioned a possible correlation between weight and pregnancy. Furthermore, 82% indicated that they think this topic should be part of the standard counseling.
Conclusions
A majority of our patients are not aware of their current BMI. These results suggest that even though patients are underreporting their BMI, they are receptive to discussing this issue with their medical providers. Ideally, increased discussions surrounding weight loss and healthy choices will lead to positive changes that will improve not only patients' BMI and lifestyle but fertility success as well. References: The State of Obesity: Better Policies for a Healthier America report (2017 Objective To investigate a possible influence of repetitive micro-traumata on the ovaries in the course of oocyte retrieval during IVF/ICSI-treatment on serum anti-Müllerian hormone (AMH) levels.
Design
Materials and Methods
To evaluate changes in serum-AMH levels on cycle day 1-3 during the course of repetitive IVF/ICSI treatments, we examined in a university clinic unit women who underwent three or more consecutive IVF/ICSI treatments between 2007 and 2017.
Results
A total of 125 patients were included in this study. Mean AMH levels before the first, second and third IVF/ICSI cycle were 3.26±4.86 ng/mL, 2.97±2.83 ng/mL and 2.76±2.60 ng/mL, respectively (pall=n.s.). In patients that underwent IVF/ICSI due to polycystic ovary syndrome (PCOS), we found a significant decrease in AMH serum levels between the first and the third (delta AMH 7.04ng/mL, p=0.038), and the second and the third cycle (delta AMH 3.65ng/mL, p=0.034). When performing a generalized linear model, we found PCOS to be an independent predictor for serum-AMH decrease during the course of three oocyte retrievals (p<0.001).
Conclusion
When comparing the indications for IVF/ICSI, we observed a significant decrease in AMH serum levels after repetitive oocyte retrievals only in women with PCOS, while the decrease in AMH was not significant in patients with tubal factor, endometriosis, male factor and unexplained infertility. This finding leads us to hypothesize, that repetitive microtraumata on the ovarian cortex might diminish/normalize functional ovarian reserve in women with PCOS. Further prospective studies are highly warranted to allow firm conclusions. 
Support None 1 8 : T H E A N T I -I N F L A M M A T O R Y E F F E C T B Y INTERACTIONS OF HUMAN BODY ANATOMICAL AXES FOR DYSMENORRHEA CAUSED BY ENDOMETRIOSIS
Material and Methods
The interaction of human human body anatomical axes via contralateral hand produces a zone with decreasing pain under the contralateral hand by the patient, which is named Ou MC decrescendo phenomenon treatment (OuDPt, Proc Physiol Soc, 2014-6, Am J Emerg Med 2012). From 2015 to 2018, 9 patients with recurrent dysmenorrhea about 6 months to 2 years after laparoscopic operation for chocolate cyst and endometriosis. Three of these patients yet had dysmenorrhea after coexisting infection treated. All of them received OuDPt in a 2 dimensional way twice daily or more in the menstrual period on the painful area.
Results
OuDPt has shown to prominently alleviate the dysmenorrhea of all 9 patients to date that they do not need other analgesic treatment.
Conclusions
Elimination of malignant changes cessation of uterine bleeding, improvement of dysfunction by OuDPt suggest tissue function normalization (TJOG, 2018 , Integr Cancer Sci Therap, 2015 . Tissue function normalization may decrease inflammatory chemicals release and thus attenuate inflammation. Displaced endometrial tissue in endometriosis act normally breaks down and bleeds with each menstrual cycle. The trapped blood and breakdown down endometrial tissue and blood irritate surrounding tissue and cause inflammation with pain. Inflammatory pain is primarily caused by the swelling tissue pushes against the sensitive nerve endings and biochemical processes during inflammation enhance pain. Tissue function normalization shows consistent short and long term effects for dysmenorrhea, which indicate OuDPt attenuate the inflammatory processes. Infertility caused by endometriosis is usually insidious and progresses gradually. A long term OuDPt may benefit preserving fertility. However, co-existing infection should be treated for that OuDPt may not be always effective against infection. 
Support None
39: INCREASED EXPRESSION OF YAP IS ASSOCIATED WITH THE DECREASED CELL AUTOPHAGY IN THE EUTOPIC ENDOMETRIAL STROMAL CELLS OF WOMEN WITH ENDOMETRIOSIS
Design
Biochemical and molecular study in primary endometrial stromal cells.
Materials and Methods
The expressions of YAP pathway and cell autophagy markers (mTOR, LC-3) in ESCs of women with or without endometriosis were validated by quantitative real-time PCR and Western blotting. The protein levels of autophagy markers were detected in the eutopic ESCs after the transfection with YAPknockdown vector and Verteporfin treatment in ESCs, respectively.
Result(s)
The mRNA levels of YAP, TEAD, mTOR were all increased in the eutopic ECSs of women with endometriosis compared with controls (P>0.05). Similarly, the protein levels of YAP (P<0.05) and mTOR(P<0.05) were significantly increased in the eutopic ECSs of women with endometriosis compared with controls, whereas the ratio of the autophagy marker protein LC3-II/LC3-I (P<0.05) was significantly decreased in the eutopic ECSs of women with endometriosis compared with controls. Furthermore, YAP knockdown and Verteporfin treatment in the eutopic ESCs increased the level of cell autophagy with an increased ratio of the autophagy marker protein LC3-II/LC3-I (P<0.05).
Conclusions
Our study demonstrates that the decreased cell autophagy level is associated with the increased expression of YAP in the eutopic ESCs and it may be negatively regulated by YAP. YAP should present a novel therapeutic method against endometriosis. 
Support
Objective
The effect of pharmaceutical increase of telomerase expression in the mouse ovary on the folliculogenesis and ovulation processes.
Design
Since many women postpone childbearing today, the decline in woman's fertility and the decrease in the number of oocytes with age is a major problem. A decrease in telomerase activity in the ovary was related to primordial follicle depletion and telomerase knockout mice were infertile. Telomerase, a ribonucleoprotein contributes to the cell proliferation capacity by the re-elongation of telomeres at the ends of the chromosomes and protects them from deleterious events. Therefore increasing telomerase in the ovary may improve fertility by influencing folliculogenesis, oocyte maturation and ovulation processes Material and Methods ICD-I female mice were injected with a single dose of telomerase increasing compounds (AGS). The estrous cycle was determined by the cell type composition of the vaginal smears. Ovaries were subjected to histological and immunohistochemestry procedures with the appropriate antibodies. Genes expression in the ovaries and gonadotropins in the pituitary gland were determined by qRT-PCR with the appropriate primers. Telomerase activity was examined by TRAP assay.
Results
We found that a single injection of AGS increased telomerase expression and activity in the mouse ovary and accelerated oocyte maturation and ovulation as indicated by the presence of many corpus luteum. The enhancement of follicle development and oocyte maturation was confirmed by the increase in the expression of associated genes. The plasma progesterone level and the expressions of the gonadotropins hormones in the pituitary gland of the AGS treated mice were compatible with the ovary state. The number of embryos increased in the AGS treated mice suggesting that the ovulation enhanced by treatment with AGS compounds was effective Conclusions These data demonstrate the importance of the transient increase of telomerase in the ovary by pharmaceutical compounds for the improvement of female fertility. Objective Since the dawn of humanity, children have been born after the death of their fathers; with the advancement of reproductive technologies, new possibilities emerged that allowed children to be conceived after the death of one or even both parents.
Support
Design
The Biological Will is legal testament that documents the intended use or disposal of any individual's sperm, ova, or embryos in case of death, incapacitation, or infertility. The Biological Will is an innovative form of legal insurance for genetic continuity. I proposed the Biological Will as a solution to the questions of gamete and embryo ownership, donor consent, legal parentage, and inheritance rights of posthumously-conceived children.
Material and Methods
Biological Wills offer singles and same-sex couples an alternative to anonymous sperm or ova donations, by receiving sperm or ova from a known donor to form a family with the donor's kin and give their child a complete genetic record. All stakeholders benefit, including, the individual that fathers or mothers the child, the designated parent who has a child that knows his or her other parent's identity, and the donor's family who continue their bloodline. The child gets a genetic record, a complete family tree, and a known extended family. The Biological Will is the only legal option for known sperm and egg donations in Israel.
Results
Since the birth of the world's first and only child to be born of posthumous maternity by Biological Will in 2011, the Biological Will has broken the boundaries of nature and made this new paradigm in ART a legal reality. 1500 Biological Wills have been composed, 100 are being implemented, and several babies have been born. (Fourie et al., 2015) .Today, laboratory's staff safety but economic considerations as well are key factors in routine ART laboratories.
Design
We developed a new device for semen processing to improve handling, safety and efficacy. Reprostar (secure sperm tube for assisted reproduction), a local prototype, is a novel tube for high security density gradient separation. Amongst fewer centrifugation steps, safe harvesting (lateral entrance of the tube) of the semen pellet is of most importance, especially for contaminated semen samples.
Material and Methods
Both techniques -standard vs Reprostar density gradient separation -have been processed in 30 semen samples. Benefits have been evaluated and compared according to: (1) simplicity, (2) gradient forming, (3) sperm pellet harvesting, (4) overall consumables and (5) sample processing time.
Results
Reprostar density gradient separation combines several improvements compared to the current standard procedure as recommended by WHO: (1) fewer handling steps, eg. washes, centrifugations, tube changes, (2) more precise and sharp separation between gradient layers, (3) a reduced risk of cross-and post-contamination while sperm pellet harvesting due to the lateral entrance, (4) less buffer solution, wash tubes and pipetting steps and (5) an overall time saving of about 50%.
Conclusions
Biosafety training and utilization of practical procedures such as sperm decontamination are fundamental tools in any laboratory's risk-reduction to prevent, reduce or eliminate infectious or sperm-harming elements.By implemetation of the Reprostar density gradient separation, we profit from a safe handling of sperm processing, while saving time and consumables. 
Support None
24: SEMEN PROCESSING -SIMULTANEOUS SWIM-UP VS SWIM-DOWN TECHNIQUE: RE-EVALUATION OF THE BENEFITS
Objective
The ideal sperm separation technique should (i) be quick, easy and costeffective, (ii) isolate as much motile spermatozoa as possible, (iii) not cause sperm damage or non-physiological alterations of the separated sperm cells, (iv) eliminate dead spermatozoa and other cells, (v) eliminate toxic or bioactive substances and (vi) allow processing of larger volumes of ejaculates.A variety of sperm separation techniques is mandatory in clinical practice to obtain an optimal yield of functionally competent spermatozoa for insemination purposes (Henkel, Schill 2003) .
Design
We developed in-house a tube prototype ("Reprostar") for gentle semen processing with focus on the swim-down method. The smart design of the tube enables direct access to the motile spermatozoa fraction at the bottom of the tube.
Material and Methods
This prospective, non-randomized study assessed seminal parameters before and after semen processing. Surplus semen aliquots derived from routine andrology patients, (n=33, mean age: 36.2±4.7) were prepared with a simultaneous swim-up (SU)/ swim-down (SD) technique followed by one washing step. Swim-down was achieved by overlaying the sperm fraction on 2ml of a 40% gradient solution (PureSperm, Nidacon). The tube was incubated 1hr at 34.5°C.
Results
Compared to the native semen (65±7.3 Mio/ml), both techniques revealed a clearly lower sperm concentration (SU 14±2.6 Mio/ml vs SD 23±3.4 Mio/ml). The proportion of WHO A-sperm was significantly increased in the SU (68±1.3) and the SD (65±1.1) procedure vs the native semen (43 ±2.5).In addition, the overall yield of the SD was about 1.5x higher as compared to the yield after SU (52.7% vs 34.2%).
Conclusions
To date, the direct SU method is the preferred technique for separating motile spermatozoa, accepting the drawback of a low yield .The benefit of the higher yield using the SD procedure could be useful for ART treatments where an increased number of spermatozoa is required. 
Support None
73: CELL-FREE DNA CONTENT AND DIFFERENTIAL APOPTOTIC GENE EXPRESSION IN BLASTOCOEL FLUID BETWEEN EUPLOID AND ANEUPLOID EMBRYOS
Objective
Selecting the best quality embryo for transfer is a demanding quest of ART, utilizing morphological assessments, embryo biomarkers or ploidy status. However, other determinants of embryo developmental potential may be employed. Apoptosis, a normal physiological process, plays a role in the correction mechanism for chromosomal abnormalities during preimplantation embryo development and leads to cell-free DNA (cfDNA) within blastocoel fluid. While blastocoel cfDNA has been used as a PGA-T source with minimal success, it may have potential as an indicator of embryonic quality. This study compared blastocoel fluid cfDNA content and apoptotic gene expression in euploid and aneuploid blastocysts.
Design
Retrospective analysis of day-5 blastocoel cfDNA content and apoptotic gene expression between euploid and aneuploid embryos.
Material and Methods
Blastocoel fluid-conditioned medium (25μL) was obtained following laser-assisted trophectoderm biopsy of ICSI-generated day-5 blastocysts. Biopsied trophectoderm were assessed via next-generation sequencing. Blastocoel fluid cfDNA was quantified via fluorospectrometry and gene expression was assessed by RT-PCR utilizing TaqMan array for human apoptosis genes (92 genes in total).
Results
Cell-free DNA was quantified in all blastocoel fluid-conditioned medium samples (35 embryos total), euploid embryos (43.15 ng/mL) had significantly (P<0.05) more (1.57X; or 56.5% greater) cfDNA than aneuploid (27.57 ng/mL) embryos. Apoptotic genes BAK1, BCL3 and IFT57 were expressed in aneuploid but not euploid blastocysts.
Conclusions
This study provides evidence that cfDNA positively correlates with embryonic ploidy status. Aneuploid, but not euploid, embryos differentially express the apoptotic genes BAK1 (BCL2 Antagonist Killer 1), BCL3 (B cell CLL/Lymphoma 3), and IFT57 (Intraflagellar Transport 57). Additional studies are warranted to further elucidate the mechanistic process by which embryos invoke apoptosis to self-correct for incidences of aneuploidy and to understand how some aneuploid embryos can implant successfully. Additionally, unique gene expression profiles may serve as biomarkers to assist in identifying the best euploid blastocyst for elective single embryo transfer. 
Support
University of South Carolina Magellan Scholar (JB) 7 4 : T W E L V E Y E A R E X P E R I E N C E O F D H E A SUPPLEMENTATION ON PREGNANCY OUTCOMES IN WOMEN WITH DIMINISHED OVARIAN RESERVE (DOR) UNDERGOING VARIOUS FERTILITY TREATMENTS
Material and Methods
We collected information on DHEA and DHEA with CoQ10-supplemented fertility cycles that included completed cycles on Letrozole, COS-IUI and IVF treatment in women with DOR who had failed to get pregnant without medication. We excluded cycles in women ≥44 years old, frozen cycles, and egg donor IVF cycles. We divided the cycles by age groups: <35yo, 35-39yo, and 40-<44yo and by supplement: DHEA and DHEA+CoQ10. The CPR was defined as an intra uterine pregnancy on ultrasound at 6 weeks gestation. Statistical analyses were performed using STATA version 11.1.
Results
A total of 2,434 DHEA-supplemented fertility cycles were included; 1,387 on Letrozole, 795 on COS-IUI and 252 on IVF. The cancellation rate in the Letrozole group was 3.75% (n=52), in the COS-IUI group was 4.4% (n=35), and in the IVF group was 23.81% (n=60). The CPR was higher in women taking DHEA+CoQ10 supplementation compared to those taking DHEA alone in women <35yo undergoing IVF (22.7% vs 85.7%, p<0.01). Even though the LBR was not statistically different between women taking DHEA compared to DHEA+CoQ10, we observed a lower LBR in those women taking DHEA+CoQ10 supplementation compared to those taking DHEA alone for each treatment mode in all age groups, except in those women 35-39 yo who underwent IVF treatmen. We still have ongoing pregnancies, 3 in the Letrozole group, 5 in the COS-IUI group and 2 in the IVF group.
Conclusions
The additional supplementation with CoQ10 increased the CPR in women taking DHEA supplementation, but did not improve LBR. Objective discovering endometrium molecular composition features and deviations underlying endometriosis and uterine myoma on various phases of women cycle.
Support None
58: LIPIDOMICS ANALYSIS OF ENDOMETRIUM FROM PATIENTS WITH ENDOMETRIOSIS AND UTERINE MYOMA
S A L I M O VA , D I N A R A 1 ; F R A N K E V I C H , V L A D I M I R 2 ; C H A G O V E T S , V I TA L I Y 2 ; T O K O R E VA ,
Design
The case-control study.
Material and Methods
Tissue samples of endometrium from 20 patients with endometriosis and 20 patients with uterine fibroids were collected during laparoscopic interventions.All samples were frozen in liquid nitrogen and stored under -80oC until the analysis. Lipid extracts were prepared according to modified Folch method and analyzed by reverse-phase liquid chromatography coupled to high-resolution mass-spectrometer with hybrid quadrupole-time-of-flight mass analizer. Obtained qualitative and semi-data were processed by partial least squares discriminant analysis method (PLS-DA) and Mann-Whitney u-test with Bonferroni correction on multiple comparisons.
Results
Multivariate analysis of mass spectrometric data revealed profound differences between lipid composition of endometrium from patients with endometriosis and with myoma. The classification mathematical model was developed allowing fast determination of an endometrium tissue origin and distinguishing lipid features of endometrium in cases under study. The following species have significantly different levels between groups with endometriosis and myoma (p-value < 0.05): OxPC 16:0/20:4, PC 18:0/20:2, PE 18:2/20:4, TG 18:1/18:1/18:2, CL 18:1/18:2/22:5/22:6, CL 18:1/ 18:2/22:6/22:6, CL 18:1/20:2/20:3/20:4, CL 18:0/20:2/22:5/ 22:6.Significant differences in lipidome were also found between endometrium in proliferative and secretory phases of menstrual cycle within groups of endometriosis or myoma.
Conclusions
Both endometriosis and uterine myoma are factors hampering women fertility. One of the reasons of such influence can be in changes of endometrium molecular composition causing changes of its receptivity. The present investigation revealed a set of lipid species with different levels in endometrium from patients with myoma and endometriosis. Analysis of signaling pathways beyond these lipids can shed some light on mechanisms of infertility and endometrium receptivity. Also, these findings can serve as a basis for the development of a new, low invasive diagnostic method.
Support
This work is supported by Russian Science Foundation project (no. 16-14-00029). Objective The pathology and mechanisms how endometriosis impairs female fertility and influences embryo development are still under debate. The aim of this study was to elucidate the possible existence of an endometriotic embryo by investigating the influence of endometriosis on a) morphokinetic parameters of embryonic development using time-lapse imaging, b) assisted reproductive technology (ART)-relevant serum parameters, c) ART-outcome such as positive heart action and live birth rate and d) the relationship between the day of embryo transfer and ART-outcome.
29: DOES THE ENDOMETRIOTIC EMBRYO REALLY EXIST
Design
Retrospective study
Material and Methods 1148 embryos (control: n=596, endometriosis: n=552) were included in the study. Embryos from patients with endometriosis were divided into the 4 ASRM stages (I-IV). The patients were stimulated with GnRH antagonist protocol. After fertilization, the embryos were incubated in a time-lapse system (EmbryoScope®). Differences between endometriosis and control groups regarding developmental stages tPNf, t2 -t9, and tMor, serum parameters (AMH, CRP, prolactin, testosterone, vitamin D), positive heart action, live birth rate, and the influence of the day of embryo transfer were evaluated.
Results
Embryos of stage IVendometriosis patients reached t6-t9 faster compared to the control group and showed the fastest development between t5-t9 within the different endometriosis stages. However, developmental times for all stages equalized at tMor. Neither serum parameters nor positive heart action and live birth rate showed differences between stages. In the endometriosis group, the least positive heart action was measured for day 4 of embryo transfer.
Conclusions
The study showed that endometriosis did not adversely affect serum parameter values nor ART-outcome, however, stage IV endometriosis could induce changes in embryonic morphokinetics which could possibly negatively impact the risk of miscarriage in stage IV endometriosis patients. Hence it is tempting to speculate that the endometriotic embryo exists, at least visible in the severe stage of the disease. Objective Time-Lapse Microscopy (TLM) is a promising, non-invasive tool in the objective evaluation of embryo development. Study objective was to examine the relationship between time-lapse parameters and ploidy in a standardized controlled ovarian stimulation (COS) cycle.
Design
This was a prospective, observational study set at a university-affiliated fertility center between 2016-2018.
Material and Methods
Women aged 21-41 years pursuing in vitro fertilization were screened using strict inclusion and exclusion criteria. All patients received a standardized controlled ovarian stimulation protocol. Oocyte retrieval was conducted 36 hours after hCG trigger, when at least 3 follicles reached 17 mm. Embryos were assessed using time-lapse parameters as well as conventional morphological assessment. Day 5 or day 6 blastocysts of good or fair quality per the Society for Assisted Reproductive Technology (SART) embryo morphology grades were biopsied for preimplantation genetic testing for aneuploidy (PGT-A). A total of 467 embryos were analyzed using time-lapse morphokinetics, of which 203 blastocysts were graded good or fair and were biopsied for PGT-A. The time-lapse parameters studied were the times between first and second cell division (P 2 ), second and third cell division (P 3 ), third and fourth cell division (P 4). Statistical analysis was performed using SPSS version 24 and Analysis of Variance (ANOVA).
Results
Of the 203 embryos that underwent PGT-A, 127 were euploid and 76 were aneuploid. There was no statistical difference in the P 2, P 3 and P 4 between euploid and aneuploid embryos. All values are presented in minutes and as mean+SD. The mean P 2 in euploid embryos was 583.7+247.0 and 607.6+ 262.3 in aneuploid embryos. The mean P 3 in euploid embryos was 173.3+ 283.2 and 194.0+302.1 in aneuploid embryos. The mean P 4 in euploid embryos was 2094.3+302.1 and 2079.4+329.6 in aneuploid embryos.
Conclusions
In this study, we found insufficient evidence to conclude that time-lapse parameters that we measured were associated with the embryo ploidy status. Objective A significant percent of morphologically and chromosomally normal embryos fail to implant, potentially due to embryo stress. Mitochondria, the cellular powerhouse, has been determined to have higher mitochondrial DNA (mtDNA) gene expression in the stressed embryo. This study assessed the effect of the maternal age, anti-mullerian hormone (AMH) concentration, and the rate of growth into a blastocyst on mtDNA expression in euploid blastocysts.
Support
Design
Prospective observational study set at a university-affiliated fertility practice between 2016 -2018.
Material and Methods
Women aged 21-41 years undergoing preimplantation genetic testing for aneuploidy (PGT-A) after in vitro fertilization were enrolled in the study. Blastocysts of good or fair quality per the Society for Assisted Reproductive Technology (SART) embryo morphology grades were biopsied for PGT-A by next generation sequencing (NGS). 155 blastocysts that were confirmed to be euploid were further tested for mtDNA scores (Mitoscore, Igenomix USA). The cut off points for assigning mtDNA scores were Mitoscore A (MsA) with a mtDNA content 50.58. MtDNA values were compared against the following variables: age of the patient, AMH concentration, and the day of blastocyst biopsy (day 5 versus day 6). MtDNA copy numbers were compared using SPSS version 24 and two-way analysis of variance (ANOVA). Spearman correlations were used for numeric or ordinal associations.
Results
Of the 155 euploid blastocysts studied, 26.4% had MsA, 56.2% had MsB, 17.4% had MsC and none had MsD. Age of the patient, AMH concentration, and the rate (day 5 versus day 6) at which the embryo develops into a blastocyst had no significant effect on the mtDNA values in euploid blastocysts.
Conclusions
In this study, mitochondrial DNA levels were not affected by age, AMH concentration and the rate at which the embryo develops into a blastocyst. 
Support
Independent Contractor
Objective Healthy live births after the transfer of aneuploid/mosaic embryos after Pre-implantation Genetic Testing for Aneuploidy (PGT-A) prove the existence of a discreet false-positive rate of the test, with risks of discarding suitable embryos for transfer. Here we sought to quantify the falsenegative rate of PGT-A using cycles in which the transfer of euploid embryos (EE) into a uterus that had eventually produced a live birth from said cycle ('proven uterus'), failed to implant.
Design
Material and Methods
Using all completed multiple-embryo transfers (MET) at our academic fertility center from 2012-2017, we identified 2749 embryos transferred in 1228 cycles to a proven uterus. Percentage of embryos lost in a proven uterus utilizing PGT-A was compared to those transferred without using PGT-A. Difference of proportions analysis using a one-tailed Z-test compared the percentage lost among proven-uterus that utilized PGT-A to cycles that did not.
Results
Twenty-eight of 1228 cycles (2.3%) transferred multiple EEs after PGT-A to a proven uterus -all double embryo transfers (DET). These cycles resulted in 14/56 EEs (25.0%) failing to implant (false-negative rate). For non-PGT-A embryos transferred to a proven uterus (DET-only cycles), 328/908 embryos (36.1%) did not implant. The difference of proportion of embryos failing to implant between proven-uterus cycles that utilized PGT-A was statistically significant when compared to DET-only controls (p = 0.046).
Conclusions
The false negative rate of PGT-A testing, whereby EEs transferred into a receptive uterus (since in the same cycle sibling embryos had implanted and produced a live birth), is 25%. This high false negative rate of PGT-A add support to the inability of PGT-A to correctly identify suitable embryos for transfer. Ongoing research may help establish the false-negative rate of PGT-A and understand whether genetic mutations and nonchromosomal errors could be responsible for lack of implantation. ; WOLCZYNSKI, SLAWOMIR determined by qRT-PCR. Changes in protein release were analyzed through ELISA. Statistical significance was assessed by one-way ANOVA using GraphPad PRISM v.7.0. P ≤ 0.05 was considered as statistically significant.
Results
P4 significantly stimulated, whereas UA at 1 μM or higher doses inhibited leiomyoma cells growth. Moreover, UA reversed the effect of P4. UA significantly decreased gene expression of IL-1β, VEGFA, VEGFC, TRAIL, IL-24, IL-10, IGF-1 and FGF2, but increased IL-10 and IFNβ1 gene expression in leiomyoma cells and tissues. Furthermore, UA significantly decreased gene expression of receptors: IL1R1, IFNAR2, TNF RSF 1A, TNF RSF 10B, TNF RSF 10C and IL10RA. UA significantly decreased IL-6, VEGF and IGF-1 release in leiomyoma cells and explants.
Conclusions
Our study showed that UA may affect the gene expression and secretion of growth factors, which may contribute to leiomyoma pathogenesis. These results might be the basis for future research on the biological treatment of uterine leiomyomas. Objective Human chorionic gonadotropin (hCG) is one of the early embryonic signals in humans, secreted by the embryo. Several studies have demonstrated its essential role in the process of blastocyst implantation and pregnancy maintenance. The goal of this study was to assess the effects of intrauterine administration of hCG one day before embryo transfer on the frequency of early pregnancy loss in infertile patients.
Support
Design
Retrospective case-control study between January 2017 and March 2018
Material and Methods
This retrospective study was done on 163 infertile patients confirmed clinical pregnancy after single blastocyst transfer in two groups: intervention group (81 patients) received 500 IU of intrauterine hCG one day before embryo transfer and control group (82 patients) did not receive hCG before embryo transfer. Early pregnancy loss was defined as spontaneous loss before 12 completed weeks of pregnancy, and was documented as the absence of fetal viability that was confirmed by the ultrasonography. A comparison was made between the studied groups of patients with respect to certain basal characteristics (age, body-mass index (BMI), and embryo quality). Statistical analysis was performed using Chi-square test to compare the differences between the two groups. Statistical significance was accepted at P ≤ 0.5.
Results
There was no significant difference between the two groups in respect to age, BMI, and the quality of the transferred embryos. The frequency of pregnancy loss in hCG group was significantly lower (27.1% (22/81); P = 0.05) in comparison with the control group (41.5% (34/82)).
Conclusions
The intrauterine administration of 500 IU of hCG one day before embryo transfer resulted in decreased frequency of early pregnancy loss in comparison with the control group. Objective Many candidate time-lapse markers have been studied regarding the selection of embryos with better chance for successful implantation. Embryonic causes of miscarriages account for 80-90% of early pregnancy loss. However, data about the relationship between embryo morphokinetics and frequency of pregnancy loss are still scarce. The objective of our study was to investigate the differences in embryo morphokinetics between a patient group with early pregnancy loss and a control group with live births.
Design
Retrospective, observational study
Material and Methods
The morphokinetics of 224 embryos which transfer resulted in early pregnancy loss was compared with that of 252 embryos which transfer resulted in live birth. All the embryos were from 476 patients undergoing ICSI treatment and day 5 single blastocyst transfers. Embryos were cultured and analyzed in EmbryoscopeTM. The comparison of 15 morphokinetic parameters (time of pronuclei appearance, time of pronuclei fading, cleavage times, morulae formation time, starting blastulation, full blastocyst stage, expansion and hatching timing) between the two patient groups was done by two-tailed ttest.
Results
Mean age, body mass index, fertilization and conventional embryology morphological parameters were not statistically different between both groups. Time lapse analysis showed that two developmental events occurred significantly later in pregnancy loss group than in live birth group -eight cells time point (t8) and nine cells time point (t9). The mean t8 and t9 values were significantly higher in the pregnancy loss group compared to the embryos from live birth group (58.28h vs. 55.89h (P=0.03) and 72.41h vs. 69.18h (P=0.04), respectively).
Conclusions
Embryos which transfer resulted in a pregnancy loss were significantly slower in reaching t8 and t9 in comparison with the control group. The transfer of human embryos with delayed developmental times t8 and t9 could lead to increased probability of occurrence of early pregnancy loss. Objective Various parameters had been used to predict ovarian response. Among them, AMH and AFC demonstrate the most favourable analytical and performance characteristics. In this pilot study, we aimed to determine the cut off levels of AMH using automated AMH assays and AFC in the prediction of poor and high responders.
Design
Prospective study of 43 women between 21-45 scheduled for Assisted Reproduction.
Material and Methods
Blood samples were collected and AMH levels were analysed on two automated analysers (Roche AMH Cobas E and Beckman Coulter DXI 800). AFC was assessed on day 3 of menses. Patients underwent IVF subsequently and the number of oocytes obtained were compared with the basal values of AFC and AMH using Statistical Program for Social Sciences (SPSS).
Results AMH (Access and Elecsys) highly correlated with AFC and the number of oocytes retrieved after ovarian stimulation. Access AMH was the best predictor for poor ovarian response with ROC AUC of 0.83. For the prediction of a high response, AFC had a higher ROC AUC of 0.95. Through ROC, the AMH level cut off for poor ovarian response are 2.23 ng/ml in Access and 2.02 ng/ml in Elecsys, while the cut off AMH level for a high ovarian response was 5.19 ng/ml in Access and 4.60 ng/ml in Elecsys. For antral follicle count, the cut off for a poor ovarian response was 18 and for a high response was 34. AFC values are higher than previous publications as current ultrasound machines have a better resolution.
Conclusions
AMH and AFC are reliable predictors of ovarian response. Establishment of specific levels may improvise individualised controlled ovarian stimulation and the obtainment of an optimal oocyte number. Larger studies are required to establish these findings.
Support
Roche and Beckman provided sample kits for the study 
Design
The aim of this study is to detect the role of angiogenesis in endometrial tissue of women who underwent ART. Within a year, samples of endometrial tissue from 8 patients who underwent ovarian stimulation were obtained. In these women other factors including BMI were also studied.
Material and Methods
Eight samples of endometrial tissue from women who underwent ovarian stimulation were collected on the day of oocyte retrieval and analyzed using the Proteome ProfilerTM Human Angiogenesis Array Kit, screening for the presence of 55 soluble angiogenesis-related factors. For the analysis, Bioinformatics (PCA procedure) and Mann-Whitney U test was used.
Results
A protein profile based on the expression of a subset of 7 factors (Angiogenin, Coagulation FactorIII, Endothelin -1, Platelet Factor 4 (PF4), Serpin F1, TIMP -1, uPA) could separate the 8 women in 2 groups. Among the group of the 4 patients with the higher expression of the 7 combined factors, 2 pregnancies were observed, while in the other group with the lower expression only a biochemical pregnancy was observed. These findings showed that despite of the limited number of patients, the results are remarkable as "angiogenic profile" of the 7 factors can not only separate the patients into 2 clusters but also classify the pregnancies in the same group, which means that a combination of angiogenic factors may contribute more than others to pregnancy achievement. The MannWhitney test was then used to study other factors (BMI, FSH, LH, endometrial thickness, number of follicles, etc). The results showed that there is a significant difference (p=0.021) in BMI between patients who achieved pregnancy and others.
Conclusions
An "angiogenic profile" could be used as a prognostic marker for ART outcome. Material and Methods A total of 68 women who underwent in vitro fertilization (IVF) treatment in the Reproductive Medicine Center of Kaohsiung Veterans General Hospital were included in this study. 28 normal ovarian responders (NORs) and 40 PORs were enrolled. PORs were assigned to receive DHEA supplementation (n=19) or not (n=21) before IVF cycles. Mitochondrial morphology of CCs was staining by mitotracker and using MicroP image analysis. Expression of mitochondrial dynamics and mitophagy-related genes in CCs was determined by Q-PCR.
Support
Results DHEA prevents mitochondrial function via decreasing the activation of Drp1, Fis1 and Mff, increasing the expression of Mfn1 and Mfn2. Upregulation of Pink1 and Parkin occurred after DHEA treatment, and increased formation of lysosomes. The results showed that DHEA could not only promote mitochondrial mass and DNA copy number but also improve mitochondrial homeostasis and dynamics in the CCs of PORs. We also observed effects with alterations in mRNA known to regulate mitochondrial biogenesis, dynamics and mitophagy in the CCs of PORs. Objective To survey the reasons for delayed childbearing and related factors among women aged at least 35 yearsseeking fertility treatment Design A cross-sectional study conducted in women aged at least 35 years attending infertility clinic in university hospital
Conclusions
Material and Methods
A self-administered questionnaire-based survey was conducted. The questionnaire consisted of background information and three domains: (1) reasons for delayed childbearing, (2) required social policy and, (3) acceptability to infertility treatment modalities.
Results 59 women (median age 38.0 years) were recruited. 86.4% of them held at least bachelor degree and 93.2% had higher income than Thailand's GDP per capita. They thought that the most appropriate age to have the first child was 28.7±2.9 years with the majority responded as 30 and 25 years (35.5% and 20.3%, respectively). The top three reasons for delayed childbearing were "more financial security", "no spouse", and "progress on my career". The participants thought that "paid paternity leave", "increase the period of paid maternity leave", and "good quality childcare" were essential for them to make an earlier decision. The most acceptable infertility treatments were intrauterine insemination, in vitro fertilization/ intracytoplasmic sperm injection, and social oocyte banking while oocyte donation, and sperm donation were the least acceptable choices.
Conclusions
The women who delayed childbearing focus on progression in their career and economic security before family completion. However, they concern about family welfare over money when it comes to family affair. The social policy and the related fertility treatment should adapt to serve the need of the people and promote national fertility rate. Design Retrospective cohort study.
Material and Methods
We did propensity score-matched analyses of the data, which included 8066 first fresh IVF / ICS I cycles f rom January 1, 2009 to December 31, 2016 .
Results
After propensity score matching, the risks of gestational diabetes mellitus, preterm birth, and small for gestational age were comparable between the PCOS and control groups for both singleton and twin births. Nevertheless, in the twin pregnancy group, women with PCOS had higher risks for hypertensive disorders of pregnancy (odds ratio [OR] 3.17, 95% confidence interval [CI]: 1.33-7.60, P=0.010), preterm premature rupture of membranes (OR 4.70, 95% CI: 1.90-11.62, P=0.001) and iatrogenic preterm birth (OR 2.71, 95% CI: 1.23-5.97, P=0.014) than the control subjects. The increased risk of iatrogenic preterm birth was eliminated after adjusting for hypertensive disorders of pregnancy. In the singleton pregnancy group, women with PCOS had lower risks for cesarean section (OR 0.58, 95% CI: 0.43-0.77, P<0.001) and iatrogenic preterm birth (OR 0.39, 95% CI: 0.19-0.80, P=0.010) than the control subjects. The decreased risks for cesarean section and iatrogenic preterm birth remained significant after adjusting for gestational diabetes mellitus and hypertensive disorders of pregnancy.
Conclusions
Women with PCOS have a higher incidence of pregnancy complications in twin pregnancies and a lower incidence of pregnancy complications in singleton pregnancies than non-PCOS women after propensity score matching. This new information may be an argument for closely monitoring women for twin pregnancies and recommending singleton pregnancies to women with PCOS undergoing IVF/ICSI. 
Design
Retrospective study in single center with in-house laboratory for PBMC product manufacture.
Material and Methods
Excluding cycles with PGD/donation/surrogacy, in 2010-2017 in our center there were 1,374 cycles with PBMC and 1,406 without (across all diagnosis and ages); at least one embryo of good morphologic quality was transferred in each cycle. Composition of PBMC with hCG was produced according to US patents 20130172666 & 20180057792. Prior to embryo transfer (ET), the 0.15-0.25 mL of suspense-like composition was delivered as intrauterine injection. Standard ultrasound diagnostics was applied to determine a clinical pregnancy (CP). Chi-square test was used for statistics.
Results
Among Fresh, 795 cycles with PBMC led to 197 CP (rate 24.8%); 1,171 non-PBMC to 204 CP (17.4%). Among Cryo, 579 cycles with PBMC led to 233 CP (40.2%); 235 non-PBMC to 74 CP (31.5%). In PBMC group, 1.62-fold increase of rate is observed for Cryo, compare to Fresh; p < .00001. For Fresh, 1.42-fold increase of rate is observed for PBMC group, compare to non-PBMC; p < .0001. For Cryo, 1.28-fold increase of rate is observed for PBMC group compare to non-PBMC; p < .05.
Conclusions
In addition to early reports about use of PBMC for RIF/ARI, now we demonstrate the efficiency of PBMC for Cryo IVF, independent of female age and number of previous IVF attempts. Early it was suggested that preparation of female organism for ET is improved due to PBMC+hCG injection. Now we additionally hipothesize about importance of embryo's signaling capability to deliver proper information to female organism in timely manner. Signaling relates to hCG emission by embryo. PBMC+hCG injection may compensate weakness of cryopreserved embryo's own signal and may lead to a better chance of successful implantation.
Support
Progena Inc. provided intellectual property and co-financing for manufacturing of PBMC product with its subsequent use in Center of Human Reproduction "Sana-Med". AF and SZ are Progena stockholders.
